baber/WOPTO huggingface dataset:
Patent NZ-583894-A (NZ)
Title: Antibodies that bind to a non atp binding p2x7 receptor
Inventor: GIDLEY-BAIRD ANGUS
IPC: A61K39/395
Filed: 2008-09-12
Abstract: Patent No. 583894 Disclosed is a peptide consisting of a sequence within the sequence KTTNVSLYPGYNFRYAKYYKENNVEKRTLIKVFGIRFDILVFGTGGKFD or consisting of the sequence KTTNVSLYPGYNFRYAKYYKENNVEKRTLIKVFGIRFDILVFGTGGKFD, said peptide being useful as an immunogen to generate an antibody that binds to a non ATP-binding P2X7 receptor but not to an ATP-binding P2X7 receptor.
Patent NZ-584230-A (NZ)
Title: A laundry hopper for use in a laundry processing apparatus
Inventor: DUCKER CHRISTOPHER ROBERT
IPC: B65G47/50
Filed: 2006-03-23
Abstract: A laundry hopper for use in a laundry processing apparatus having a track is disclosed. The hopper includes: a container for receiving laundry; an opening in the container for receiving and dispensing laundry; connecting means for connecting the hopper to the track; and pivot means to permit tilting of the container with respect to the connecting means, which facilitates loading and unloading of the hopper so that laundry can be received and dispensed through the opening.
Patent NZ-587439-A (NZ)
Title: Use of ulipristal for treating uterine fibroids
Inventor: GAINER ERIN
IPC: A61K31/57
Filed: 2009-01-28
Abstract: Disclosed is The use of an effective amount of 17alpha-acetoxy-11beta-[4-N, N-dimethylamino-phenyl)-19-norpregna- 4, 9-diene-3, 20-dione (ulipristal acetate) or any metabolite thereof for the manufacture of a medicament for reducing or stopping bleeding in a patient afflicted with uterine fibroids; preventing or treating anaemia in a patient afflicted with uterine fibroids or treating metastatic leiomyoma. The ulipristal acetate metabolite is selected from the group consisting of CDB-3877, CDB-3963, CDB-3236, and CDB-4183.
Patent NZ-589269-A (NZ)
Title: Combination therapy with an antitumor alkaloid
Inventor: LEPAGE DOREEN
IPC: A61K31/4745
Filed: 2009-05-18
Abstract: 589269 Disclosed is the use of PM00104, or a pharmaceutically acceptable salt thereof, in combination with another anticancer drug selected from tyrosine kinase inhibitors, mTOR inhibitors, antitumor platinum coordination complexes, antimetabolites, anthracyclines, topoisomerase I and/or II inhibitors, and antitumor monoclonal antibodies, for the manufacture of a medicament for the treatment of a cancer selected from lung cancer, pleural mesothelioma, bladder carcinoma, pancreas carcinoma, gastric carcinoma, ovarian cancer, and breast cancer, wherein the medicament comprises synergistic properties.
Patent NZ-591405-A (NZ)
Title: Tractor mountable splitter to cut through wrapped bale and retain wrapping via grab after split bale has been discharged
Inventor: MURPHY WILLIAM KIERAN
IPC: A01F29/00
Filed: 2009-08-07
Abstract: A bale splitter (1 ) for mounting on a front end loader arm of a tractor' comprises a support framework (5) having a plurality of tines (7) extending transversely therefrom for supporting a cylindrical wrapped bale (2). A pair of carrier arms (15) pivotally coupled to the support framework (5) carry a cutting blade (20) for splitting the bale (2) and for simultaneously cutting wrapping material of the bale (2). The cutting blade (20) is slightly spaced apart from the tines (7) for preventing cutting of the wrapping material (4) adjacent the tines (7) so that the wrapping material remains in one single integral piece after splitting of the bale (2). A grab (30) comprising jaws (32,33) is supported on the support framework (5) to abut the bale (2) when supported on the tines (7), and for gripping the wrapping material (4) prior to operation of the cutting blade (20) for cutting the bale (2). By tilting the bale splitter (1) the split bale is discharged and the wrapping material (4) still gripped by the grab (30) is thus separated from the split bale.
Patent NZ-593906-A (NZ)
Title: Gpr120 receptor agonists and uses thereof
Inventor: SHI DONG FANG
IPC: A61K31/343
Filed: 2009-12-17
Abstract: Disclosed herein are benzofuran compounds of general formula (C), wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful as GPR120 agonists (gastrin releasing peptide), as such are useful in the treatment of Type I or II diabetes and metabolic syndrome. Examples of particularly preferred compounds include: 3-(2,6-difluoro-4-((5-fluoro-2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)methoxy)phenyl)propanoic acid; 3-(2-bromo-4-((5-chloro-2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)methoxy)-5-methoxvphenyl)propanoic acid; 3-(4-((5-(3-chlorophenyl)-2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)methoxy)phenyl)-2-methylpropanoic acid; 2-(4-((5-fluoro-2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)methoxy)phenyl)cyclopropanecarboxylic acid; 3-(4-((5-chloro-2,2-dimethyI-2,3-dihydrobenzofuran-7-yl)methoxy)-2-(trifluoromethoxy)phenyI)propanoic acid.
Patent NZ-594924-A (NZ)
Title: Diaper sheath with adjustable sides
Inventor: TOURNIER GAELLE
IPC: A61F13/74
Filed: 2011-08-31
Abstract: 594924 A diaper sheath comprises a shell having an inner panel and an outer panel, with each of the inner and outer panels having a front portion and a back portion. Each panel is attached peripherally one to the other in matched contour to form a front edge, a back edge, and a first side edge and a second side edge. A first intermediate pocket 105 and a second intermediate pocket 107 are set along the first side edge and the second side edge respectively. Each intermediate pocket has at least one opening. A first intermediate strip 1810 and a second intermediate strip 1812 are set inside each of the first and second intermediate pockets respectively. The first and second intermediate strips each have an anchor portion attached to an attachment ring, and an elongated portion having a loop formed through a slide. The loop passes through the attachment ring and has a continuously adjustable length selected by moving the slide to a desired position along the elongated portion.
Patent NZ-595476-A (NZ)
Title: Plant snf1-related protein kinase gene
Inventor: ZHENG ZHIFU
IPC: C12N15/54
Filed: 2010-04-09
Abstract: Disclosed is a process for producing a plant, plant seed or progeny thereof, the process comprising: transforming a plant cell with a heterologous nucleic acid encoding a Snf1-related protein kinase 2-6 protein (SnRK2-6 protein), wherein the nucleic acid encoding the SnRK2-6 protein comprises the nucleotide sequence according to SEQ ID NO: 3 or a nucleotide sequence that is at least 85% identical to the sequence according to SEQ ID NO: 3; growing a plant from the plant cell until the plant produces seed; and harvesting the seed from the plant. The sequences are as defined in the specification.
Patent NZ-600170-A (NZ)
Title: Stream-based software application delivery and launching system
Inventor: URBACH JULIAN MICHAEL
IPC: G06F9/30
Filed: 2010-11-23
Abstract: A method for distributing software over a computer network is disclosed where a first computer system receives a software stub comprising a URI (Uniform Resource Identifier) identifying a downloadable software program from a second computer system. The first computer system installs the received software stub. The software stub transmits a request for an executable code of the downloadable software program. The request comprises the URI. The software stub on the first computer system receives the executable code of the downloadable software program in a data stream transmitted from the second computer system over a network connection between the first computer system and the second computer system. The data stream comprises executable code of a software program and the first computer system extracts the executable code of the downloadable software program from the data stream. The first computer system allocates an amount of dynamic memory for the executable code of the downloadable software program and the first computer system loads the executable code of the downloadable software program extracted from the data stream directly into the allocated dynamic memory so that the executable code of the software program is not stored or installed on a permanent storage of the first computer system. The first computer system executes the downloadable software program by launching the executable code of the downloadable software program loaded in the allocated dynamic memory. Also disclosed is the first computer system configured to carry out the above described method of distributing software over a computer network. Also disclosed is a method for distributing software over a computer network where a processor associated with a server system configures a software stub to comprise a URI (Uniform Resource Identifier) identifying a downloadable software program. The processor transmits the software stub for installation to a client system and the processor enables the client system to map the URI to an IP (Internet Protocol) address of the server system. The processor receives a request for an executable code of the software program from the stub. The request comprises the URI and the processor configures a data stream to comprise the executable code of the software program such that the executable code of the software program is extracted and loaded from the data stream directly into allocated dynamic memory of the client system so that the executable code of the software program is not stored or installed on a permanent storage of the client system. The processor then transmits the data stream to the client system.
Patent NZ-603993-A (NZ)
Title: Spatial logical and skill improvement game, particularly a labyrinth game
Inventor: ZAGYVAI ANDRAS
IPC: A63F9/00
Filed: 2010-05-05
Abstract: 603993 A spatial logical and skill improvement game includes a body (1) consisting of coaxial body portions arranged at one or multiple layers, a labyrinth being formed inside the body and/or the body portions by path sections, pockets and ends. The game comprises at least one toy element in the form of a stick (7) with a head at each end being movable through the path sections, pockets, and ends constituting the labyrinth.
Patent NZ-621812-A (NZ)
Title: Fair scheduling for mixed-query loads
Inventor: MICHAEL HARRIS
IPC: G06F17/30
Filed: 2014-02-27
Abstract: Disclosed is a computer-implemented method performed by one or more computing devices (100). The method includes obtaining a computer-executable query job and a cost estimate to execute the query job and, based on the cost estimate exceeding a threshold cost, determining to divide the query job into a plurality of computer-executable sub-query tasks. Each of the plurality of sub-query tasks is separately executed by a database management system (106). The database management system (106) initiates an execution of a first sub-query task of the plurality sub-query tasks, the first sub-query task including a result limiter that limits the number of results returned by the first subquery task. After the database management system (106) has finished executing the first sub-query task, a value of a last result returned is determined by the database management system (106) for the first sub-query task. The database management system (106) then initiates execution of a next sub-query task of the plurality of sub-query tasks, the next sub-query task including the determined value of the last result returned by the database management system (106) for the first sub-query task.
Patent NZ-623949-A (NZ)
Title: Haemostatic material
Inventor: HARDY CRAIG
IPC: C08L5/08
Filed: 2009-04-27
Abstract: Disclosed is a haemostatic material comprising a carrier layer, an adhesive layer comprising a bonding agent wherein the bonding agent is a meltable material operable to bond the haemostat and the carrier layer using heat, and a material for wound contact comprising at least one haemostat in particulate, granular, powder, flake or short fibrous form, wherein the haemostat comprises a chitosan salt such as chitosan acetate, chitosan lactate, chitosan succinate, chitosan malate, chitosan sulphate, or chitosan acrylate. Also disclosed is a method of manufacturing a haemostatic material according as defined above, comprising the steps of: i. providing a carrier layer; and ii. contacting a quantity of a haemostat to the carrier layer, wherein the haemostat is in particulate, granular, powder, flake or short fibrous form, wherein the haemostat comprises a chitosan salt, wherein the haemostat is maintained in contact with the carrier layer using an adhesive layer comprising a bonding agent wherein the bonding agent is a meltable material.
Patent NZ-624232-A (NZ)
Title: Cladding element
Inventor: SOUTHWELL DARREN
IPC: E04F13/16
Filed: 2012-11-21
Abstract: A fibre cement cladding element 100, suitable for use in a building envelope, comprising a first face 101, a second face 102 and a peripheral edge member, the first face 101 and second face 102 being spaced apart to define an intermediate portion of predetermined thickness (t), the peripheral edge member extending around the intermediate portion. The first face 101 comprises a first profiled portion 106 adjacent at least a portion of the peripheral edge member. The first profiled portion 106 of the first face 101 comprises an exposed recessed portion 107 that is exposed thereby simulating a recessed mortar joint in a constructed wall, a fixing zone intermediate the recessed portion and the at least a portion of the peripheral edge member, and an angled portion 108 intermediate the first face 101 and recessed portion 107. The angled portion 108 comprises an acute angle of between 20 to 75 degrees relative to the plane of the first face immediately adjacent the profiled portion. The first profiled portion is configured to provide an improved shadow zone contrast by substantially containing the shadow zone from an edge of an adjacent cladding element on to the exposed recessed portion. The peripheral edge member comprises a first profiled edge portion and a second profiled edge portion. Each of the first and second profiled edge portions comprises a releasably engageable mutually complementary shiplap profile and the second face is generally planar.
Patent NZ-630287-A (NZ)
Title: Crystalline bortezomib process
Inventor: CHATURVEDI AKSHAYKANT
IPC: A61K31/60
Filed: 2013-11-12
Abstract: The disclosure relates to a process for the preparation of crystalline Bortezomib (Ia) as its monohydrate which is designated as crystalline Form-SB (Ia) and characterized by having water content ranging between 3.5 - 6.0 % w/w; X-ray powder diffraction pattern comprising characteristic 2θ° peaks selected from the XRPD peak set of 5.6, 7.5, 9.8, 10.2, 11.3, 15.1, 18.0, 20.5, 21.5and 23.6 ± 0.20 2θ°, wherein peaks at 9.8 and 11.39 ± 0.20 2θ° are un-split and 100 % intensity peak is present at 5.6± 0.20 2θ°, DSC isotherm comprising the endothermic peaks ranging between 45 to 60°C (Peak -1) and 175 to 185°C (Peak -2) and IR absorption characteristic peaks approximately at 3387 cm-1, 3304 cm-1, 2953 cm-1,2927 cm-1, 2868 cm-1, 1627 cm-1, 1455 cm-1, 1400 cm-1, 1201cm-1, 1150cm-1, 1020 cm-1, 747 cm-1and 702 cm-1and Raman absorption spectra having characteristic peaks approximately at 3066 cm-1, 1583 cm-1, 1528 cm-1,1281cm-1, 1213 cm-1, 1035 cm-1, 1022cm-1and 1004 cm-1, wherein the process comprises the steps of: (a) combining the Bortezomib with an aliphatic ester solvent or a mixture of aliphatic ester solvent and water; (b) raise the temperature upto about 40- 70°C; (c) stir the solution at same temperature up to a time between 15 to 60 minutes; (d) combine with aliphatic C6 to C7 hydrocarbon solvent; (e) optionally maintain the mixture for 10-60 minutes; (f) cooling the mixture upto about 10-40°C; and (g) isolating the crystalline material. Said crystalline Form-SB of Bortezomib is used as an active pharmaceutical ingredient in pharmaceutical compositions for the treatment of cancer.
Patent NZ-630368-A (NZ)
Title: Flow cytometer nozzle tip
Inventor: BUCHANAN KRIS
IPC: G01N15/14
Filed: 2013-09-19
Abstract: A nozzle tip for a flow cytometer system is disclosed. The tip is formed from a cylindrical body (80) defining a longitudinal axis (16) and a frustoconical body (84) adjoining the cylindrical body on the longitudinal axis. The cylindrical body is in fluid communication with the frustoconical body. The frustoconical body has an end with a flat surface having a nozzle exit orifice which is transverse to the longitudinal axis. A cutout (88) at the edge of the frustoconical body and the flat surface prevents occluding emissions and reflecting secondary emissions. The flow cytometer system may also include a source of electromagnetic radiation for producing a beam incident upon the fluid stream and the particles and a detector for detecting light emitted or reflected from the particles within the fluid stream in response to the beam.
Patent NZ-630558-A (NZ)
Title: Coupling an upper end of a hollow section column to a building unit support
Inventor: BERNARD KENNELLY
IPC: E04C3/30
Filed: 2014-09-09
Abstract: A fitting for coupling an open upper end of a hollow section column to a support is disclosed. A building unit is to be supported on the column via the fitting. The fitting (10) comprising a body portion, configured to be received in the end of the hollow column (50), and rim portions (15) which extend laterally outwardly from an upper end of the body portion so as to engage edge sections (52) of upper end of the column. An assembly of the fitting, column and foundation is also disclosed. A seat that fits within the body portion is also disclosed which acts to spread the load of the supported structure over a wider area. The fitting and the cup are formed by bending respective blanks. The blanks may be pre-treated with an anticorrosion coating before being bent. The system as a whole allows simple and quick connection to “cassette” type flooring systems.
Patent NZ-706687-A (NZ)
Title: Fiber optic cassette
Inventor: MURRAY DAVID PATRICK
IPC: G02B6/40
Filed: 2013-09-25
Abstract: As demand for telecommunications increases, fiber optic networks are being extended in more and more areas. Management of the cables, ease of installation, and case of accessibility for later management are important concerns. As a result, there is a need for fiber optic devices which address these and other concerns. As a solution, or a useful alternative, to one or more to the above described technical problems, the present invention provides a fiber optic cassette includes a body defining a front and an opposite rear. A cable entry location is defined on the body for a cable to enter the cassette, wherein a plurality of optical fibers from the cable extend into the cassette and form terminations at non-conventional connectors adjacent the front of the body. A flexible substrate is positioned between the cable entry location and the non-conventional connectors adjacent the front of the body, the flexible substrate rigidly supporting the plurality of optical fibers. Each of the non-conventional connectors adjacent the front of the body includes a ferrule, a ferrule hub supporting the ferrule, and a split sleeve surrounding the ferrule.
Patent NZ-707315-A (NZ)
Title: Reciprocating low-speed heavy-load hydraulic pump with variable action area
Inventor: SUN WEI
IPC: F04B49/18
Filed: 2012-09-25
Abstract: A reciprocating low-speed heavy-load hydraulic pump with a variable action area comprises a plurality of hydraulic cylinder units (3) and moving members (1, 2). Two ends of the hydraulic cylinder units (3) are separately connected with the moving members (1, 2) via mechanical structures. The moving members (1, 2) move relative to each other. The hydraulic cylinder unit (3) consists of a hydraulic cylinder (4), a reversing valve (5) and a one-way valve (6). The hydraulic cylinder (4), the reversing valve (5) and the one-way valve (6) are connected with each other via hydraulic pipelines. Based on different magnitudes of driving force, the hydraulic pump can proactively configure and form different combinations of hydraulic cylinder units, and further adjust the size of an equivalent action area. Therefore, even if the magnitude of the driving force changes, it can be ensured that the hydraulic pump consisting of hydraulic cylinder units outputs oil liquid with a relatively stable pressure for use by a subsequently connected system. The reciprocating low-speed heavy-load hydraulic pump with a variable action area is advantageous in high conversion efficiency, a simple system structure and good working stability.
Patent NZ-708086-A (NZ)
Title: 3-(4’-substituted)-benzyl-ether derivatives of pregnenolone
Inventor: PIAZZA PIER VINCENZO
IPC: C07J41/00
Filed: 2013-11-27
Abstract: The metabolism of neuroactive steroids into metabolites that exhibit different pharmacological profiles as compared to their precursors is responsible for the variety of effects of a single steroid. As yet, no derivative of naturally occurring or synthetic steroids that avoid side effects due to its metabolization has been developed. The inventors have found that molecules derived from pregnenolone that contain a 3-benzyloxy function (substituted or not) cannot be converted into metabolites endowed with progestative, androgenic, estrogenic, glucocorticoid activity and neuromodulator properties. Therefore, using these pregnenolone derivatives that are not or not substantially converted into pregnenolone metabolites avoids side effects. The invention relates to a compound of Formula (I):
Patent NZ-715131-A (NZ)
Title: A method, a device and a system for detecting a state of an animal
Inventor: HARTY EDMOND PATRICK
IPC: A01K29/00
Filed: 2014-06-16
Abstract: A device (5) attached to the neck (6) of an animal (2) comprises an accelerometer (28) which produces first and second signals indicative of movement of the animal (2) and the raised and lowered states of the head of the animal. A microprocessor (30) in the device (5) processes the first and second signals to detect at least one detectable state of the animal. Data indicative of the states of the animal is stored by the microprocessor (30) in the device (5) and periodically transmitted to a cloud computer server which further processes the data to determine various health states and other issues of the animal, wherein the method for detecting the at least one detectable state of the animal, comprises: computing a mean magnitude value of the first signal indicative of movement of the head of the animal from the acceleration sensor during each first predefined time period of a plurality of first predefined time periods, counting the numbers of positive and negative peaks of the first signal during each first predefined time period, the absolute magnitude values of which with reference to the mean magnitude value lie within a predefined range of absolute magnitude values, computing the maximum peak to peak value of the first signal during each first predefined time period as the sum of the absolute magnitude values of the maximum positive peak value with reference to the mean magnitude value and the maximum negative peak value with reference to the mean magnitude value of the first signal during the corresponding first predefined time period, and detecting the at least one detectable state of the animal during each first predefined time period in response to at least one of the value of the count of the positive and negative peak values of the first signal which lie within the predefined range of absolute magnitude values during the corresponding first predefined time period, and the computed maximum peak to peak value of the first signal during the corresponding first predefined time period.
Patent NZ-727092-A (NZ)
Title: Improved polyethyleneimine polyethyleneglycol vectors
Inventor: LEVITZKI ALEX
IPC: C07K17/06
Filed: 2015-05-14
Abstract: A polyplex of a double stranded RNA and a polymeric conjugate is provided, wherein the polymeric conjugate consists of a linear polyethyleneimine covalently linked to one or more polyethylene glycol (PEG) moieties, each PEG moiety being conjugated via a linker to a targeting moiety capable of binding to a cancer antigen.